• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Methylprednisolone Sodium Succinate Injection

 Status: Resolved

 » Duration of Shortage: 02/14/2014 - 08/08/2014
 » Therapeutic Categories: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pediatric; Pulmonary/Allergy; Renal; Rheumatology

Pfizer Pharmaceuticals (Revised 08/08/2014)

Company Contact Information:
800-533-4535

Presentation
  • Solu-Medrol 40mg Act-O-Vial 25s (NDC 0009-0039-28)
  • Solu-Medrol 40mg Act-O-Vial 25s (Novaplus) (NDC 0009-0039-32)
  • Solu-Medrol 125mg Act-O-Vial 25s (NDC 0009-0047-22)
  • Solu-Medrol 125mg Act-O-Vial 25s (Novaplus)(NDC 0009-0047-26)
  • Solu-Medrol 500mg MD Vial 1s (NDC 0009-0758-01)
  • Solu-Medrol 500mg Act-O-Vial 1s (NDC 0009-0003-02)
  • Solu-Medrol 1g MD Vial 1s (NDC 0009-0698-01)
  • Solu-Medrol 1g Act-O-Vial 1s (NDC 0009-0018-20)
  • Solu-Medrol 2g MD Vial 1s (NDC 0009-0796-01)
Note:
  • No further supply issues anticipated.
-
-